Table 2. Analysis of the correlation between serum RBP4 and FPG, OGTT, HOMA-IR and FINS in five groups of women.
Groups | FPG | OGTT1h | OGTT2h | FINS | HOMA-IR |
---|---|---|---|---|---|
GDM group at the middle stage | |||||
r | −0.05 | 0.06 | 0.07 | 0.91 | 0.75 |
P | 0.45 | 0.37 | 0.36 | <0.01 | <0.01 |
GDM group at the late stage | |||||
r | −0.25 | 0.79 | 0.48 | ||
P | 0.73 | <0.01 | <0.01 | ||
Control group at the middle stage | |||||
r | 0.07 | −0.29 | <0.01 | 0.91 | 0.85 |
P | 0.54 | 0.02 | 0.99 | <0.01 | <0.01 |
Control group at the late stage | |||||
r | −0.04 | 0.95 | 0.82 | ||
P | 0.76 | <0.01 | <0.01 | ||
GDM postpartum group | |||||
r | 0.16 | 0.06 | −0.04 | 0.83 | 0.76 |
P | 0.1 | 0.56 | 0.68 | <0.01 | <0.01 |
FPG, fasting plasma glucose; FINS, fasting insulin; RBP4, retinol-binding protein 4; GDM, gestational diabetes mellitus; HOMA-IR, insulin resistance index.